glp-1 drugs food industry impact news today The Boom Is Rewriting the Future of Packaged Nutritional priorities to support GLP-1
Description
10.3389/fcell.2020.602574 18 FengJ.TengZ.YangY.LiuJ.ChenS

Key takeaways include: Obesity drug coverage in Medicaid remains limited, with 13 state Medicaid programs covering GLP-1s for obesity treatment under fee-for-service (FFS) as of January 2026
Lawrence D, Hancock KJ, Kisely S

Li Q, Tuo X, Li B, Deng Z, Qiu Y, Xie H

Desire to avoid mealtime insulin injections